Literature DB >> 11950183

Obstetric cholestasis, outcome with active management: a series of 70 cases.

Anna P Kenyon1, C Nelson Piercy, J Girling, C Williamson, R M Tribe, A H Shennan.   

Abstract

OBJECTIVE: To determine the nature and outcome of obstetric cholestasis in a United Kingdom population.
DESIGN: Prospective analysis of clinical outcome in women diagnosed with obstetric cholestasis that is actively managed.
SETTING: Antenatal population of three London hospitals between August 1999 and April 2001. POPULATION: Seventy women with obstetric cholestasis defined as abnormal liver function (one or more abnormality in gamma-glutamyl transpeptidase, alanine amino-transferase, aspartate amino-transferase and total bile acids) in a pregnant woman with pruritus, in the absence of other pathology.
METHODS: All women were interviewed weekly regarding their symptoms. All were actively managed according to a standardised protocol, which included early delivery before 38 weeks. Obstetric outcome was recorded.
RESULTS: Seventy women of mean age 30 (6) years delivered 73 infants. The median gestation at onset of pruritus was 30 (range 4-39) weeks and at diagnosis of obstetric cholestasis was 33.7 (range 21-40.7) weeks. Asian women were more likely to be diagnosed with obstetric cholestasis. Pruritus was usually severe and generalised, and commonly worst on the palms and/or soles of the feet. There were no stillbirths or perinatal deaths. Twenty-five women required caesarean section (36%); only four (16%) were for fetal distress. Twelve women (17%) delivered before 37 weeks, of which eight (67%) were iatrogenic. Ten (14%) infants required admission to the special care baby unit of which four (40%) were ventilated.
CONCLUSIONS: Policies of active management result in increased intervention and associated complications. This must be balanced against possible reductions in perinatal mortality.

Entities:  

Mesh:

Year:  2002        PMID: 11950183     DOI: 10.1111/j.1471-0528.2002.01368.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  30 in total

Review 1.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

2.  HELLP syndrome preceded by intrahepatic cholestasis of pregnancy: one serious itch.

Authors:  Jiska Jebbink; Merit Tabbers; Gijs Afink; Ulrich Beuers; Ronald Oude Elferink; Carrie Ris-Stalpers; Joris van der Post
Journal:  BMJ Case Rep       Date:  2014-04-07

3.  Obstetric Outcome During an Era of Active Management for Obstetrics Cholestasis.

Authors:  Nalini Sharma; S Panda; Ahanthem Santa Singh
Journal:  J Obstet Gynaecol India       Date:  2015-09-08

Review 4.  The molecular genetics of intrahepatic cholestasis of pregnancy.

Authors:  P H Dixon; C Williamson
Journal:  Obstet Med       Date:  2008-12-01

5.  Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis.

Authors:  A P Kenyon; R M Tribe; C Nelson-Piercy; J C Girling; C Williamson; P T Seed; S Vaughan-Jones; A H Shennan
Journal:  Obstet Med       Date:  2010-03-04

6.  Intrahepatic Cholestasis of Pregnancy.

Authors:  Frank Lammert; Hanns-Ulrich Marschall; Siegfried Matern
Journal:  Curr Treat Options Gastroenterol       Date:  2003-04

7.  ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy.

Authors:  R Müllenbach; A Bennett; N Tetlow; N Patel; G Hamilton; F Cheng; J Chambers; R Howard; S D Taylor-Robinson; C Williamson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 8.  Interventions for treating cholestasis in pregnancy.

Authors:  Vinita Gurung; Philippa Middleton; Stephen J Milan; William Hague; Jim G Thornton
Journal:  Cochrane Database Syst Rev       Date:  2013-06-24

9.  Predictors of adverse neonatal outcomes in intrahepatic cholestasis of pregnancy.

Authors:  Tetsuya Kawakita; Laura I Parikh; Patrick S Ramsey; Chun-Chih Huang; Alexander Zeymo; Miguel Fernandez; Samuel Smith; Sara N Iqbal
Journal:  Am J Obstet Gynecol       Date:  2015-06-10       Impact factor: 8.661

10.  Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump.

Authors:  Yvonne Meier; Tina Zodan; Carmen Lang; Roland Zimmermann; Gerd A Kullak-Ublick; Peter J Meier; Bruno Stieger; Christiane Pauli-Magnus
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.